Solid Tumor Cancer
50
23
24
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.0%
1 terminated out of 50 trials
90.9%
+4.4% vs benchmark
2%
1 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (50)
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
Imaging of Solid Tumors Using DLL3 SPECT
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans
Study of DF6215 in Patients With Advanced Solid Tumors
QLS5212 for Participants With Advanced Solid Tumors
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application
Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903
Implementation of the Methylome in the Characterization of Solid Tumors
A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors
A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Previously Treated Cancers